Home > Healthcare > Biotechnology > Biopharma > Protein Engineering Market

Protein Engineering Market Share

  • Report ID: GMI8008
  • Published Date: Feb 2024
  • Report Format: PDF
 Download Free Sample

Protein Engineering Market Share

The protein engineering industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., Bristol Myers Squibb Company, among others have a notable presence in the market.
 

Protein Engineering Market Companies

Some of the eminent market participants operating in the protein engineering industry include:

  • Agilent Technologies, Inc.
  • Amgen Inc.
  • Bio-Rad Laboratories, Inc.
  • Bristol Myers Squibb Company
  • Bruker Corporation
  • Danaher Corporation
  • Genentech, Inc.
  • Integrated DNA Technologies, Inc.
  • Lonza Group
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global protein engineering industry was valued at around USD 2.5 billion in 2023 and is estimated to reach over USD 9.3 billion by 2032 owing to the rising frequency of protein-deficient disorders such as marasmus and kwashiorkor, particularly in developing and underdeveloped countries.

The reagents segment will record significant growth rate at 16.2% from 2024 to 2032, fueled by increasing use of reagents for a wide range of applications, including the synthesis of growth factors, monoclonal antibodies, vaccines, and other medicines.

North America protein engineering market accounted for USD 1.01 billion in 2023 and is predicted to witness substantial growth through 2032, owing to increased chronic disease prevalence, high healthcare spending, favorable government policies, and increasing use of protein medications over non-protein drugs.

Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., Bristol Myers Squibb Company, Bruker Corporation, Danaher Corporation, Genentech, Inc., Integrated DNA Technologies, Inc., Lonza Group, Merck KGaA, Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Incorporated.

Protein Engineering Market Scope

  • Protein Engineering Market Size
  • Protein Engineering Market Trends
  • Protein Engineering Market Analysis
  • Protein Engineering Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 12
    • Tables & Figures: 276
    • Countries covered: 22
    • Pages: 155
     Download Free Sample
    ×
    Get a free sample of Protein Engineering Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.